Start of Intnl. Conf. In Germany. 18-22 Sept.
The “Photodynamic Therapy and Photodiagnostics Update” conference is a highly regarded event in the field of Photo Dynamic Therapy (“PDT”) bringing together researchers and clinicians working in all fields of PDT and Photo Diagnosis (“PD”) to foster scientific development of this technology in the fields of biology and medicine.
Arkady Mandel, MD, PhD, DSc., Interim Chief Executive Officer and Chief Scientific Officer, Theralase said “The latest Theralase sponsored research to be presented titled, “Monitoring of cell metabolism during PDT” authored by Svietlana Kalinina, Lothar Lilge, Arkady Mandel and Angelica Rueck, reveals that Theralase’s lead PDC, TLD-1433, is a highly efficient anti-cancer PDC that is able to detect and/or monitor the oxygenation level in cancerous tumours before and during PDT